OpenAI

OpenAI is the AI research and product company behind ChatGPT and the GPT model family, and arguably the company most responsible for making generative AI a mainstream consumer and enterprise product rather than a research curiosity. Founded in 2015 in San Francisco as a nonprofit research lab, OpenAI restructured over time into a "capped-profit" company under nonprofit oversight in order to raise the enormous capital its ambitions required, a structure that remains a point of ongoing legal and public debate as the company edges toward a full public listing.

OpenAI's growth over the past two years has been extraordinary by almost any startup benchmark: annualized revenue exceeded $20 billion at the end of 2025, roughly triple its 2024 level, and by mid-2026 the company was generating an estimated $2 billion per month, putting its annualized run rate above $25 billion. ChatGPT itself has become one of the most widely used consumer products in history, crossing 900 million weekly active users and 1 billion monthly active users, with 92% of Fortune 500 companies reportedly using it in some capacity — a penetration rate that few enterprise software products, let alone a company barely a decade old, have ever achieved this quickly.

That growth has been financed by an equally extraordinary run of capital-raising. OpenAI's valuation reached $852 billion following a March 2026 funding round that brought in $122 billion of fresh capital — the largest private-company valuation on record at the time. The company filed a confidential S-1 with the SEC in May 2026, working with Goldman Sachs, Morgan Stanley, and JPMorgan on a prospective public listing, with CEO Sam Altman initially targeting a September 2026 debut. By late June 2026, however, reporting suggested OpenAI was leaning toward delaying the actual listing into 2027 rather than accept a lower valuation in a 2026 offering — Altman has been quoted describing any meaningful discount from a targeted roughly $1 trillion valuation as a "non-starter," underscoring how much of OpenAI's near-term strategy is now shaped by valuation negotiations as much as by product or research priorities.

OpenAI's position is unusual in a specific way worth noting for anyone evaluating the company: Altman himself owns no equity in OpenAI, an arrangement that has raised its own governance questions even as OpenAI's investors — most prominently Microsoft, which supplies much of OpenAI's cloud computing infrastructure and has deep product integration through Copilot — have poured tens of billions of dollars into the company. That Microsoft relationship is both OpenAI's greatest structural advantage (guaranteed large-scale compute and enterprise distribution) and a long-term complication, since Microsoft's own AI ambitions and OpenAI's commercial interests as an increasingly independent, IPO-track company don't perfectly align over time.

The larger risk to OpenAI's business is one shared by the entire generative AI sector: the enormous, compounding cost of training and running frontier models, competition from well-capitalized rivals (Google's Gemini, Anthropic's Claude, and a fast-growing set of open-source and Chinese models), and a valuation that already prices in years of continued explosive growth. Whether OpenAI's revenue growth can keep pace with its costs and its valuation — rather than requiring perpetual new funding rounds to stay afloat — is the central question hanging over the company as it approaches, and possibly delays, becoming a public one.